Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung (ERBIFORT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00557102 |
|
Recruitment Status :
Completed
First Posted : November 12, 2007
Last Update Posted : December 11, 2012
|
Sponsor:
National Cancer Institute, France
Collaborator:
University Hospital, Grenoble
Information provided by (Responsible Party):
National Cancer Institute, France
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2010 |
| Actual Study Completion Date : | December 2010 |